ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO395

Gut Flora-Dependent Metabolite Trimethylamine-N-Oxide Accelerates Kidney Aging Through p53/p21/Rb Pathway and Age-Related CircRNAs

Session Information

  • CKD: Mechanisms - II
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms


  • Gao, Fanfan, First Affiliated Hospital of Medicine School, Xi'an Jiaotong University, Xi'an, Shaanxi, China
  • Jiang, Hongli, First Affiliated Hospital of Medicine School, Xi'an Jiaotong University, Xi'an, Shaanxi, China

Gut microbiota can influence the aging process and may modulate aging-related changes in cognitive function. Trimethylamine-N-oxide (TMAO), gut microbiota-dependent metabolites, has been shown to be associated with kidney diseases and other disease. However, the relationship between TMAO and aging, especially renal aging, has not been fully elucidated.


We analyzed age-related palsma levels of TMAO and circRNAs in 3-month-old and 24-month-old C57BL/6 mice. Then HK-2 and TCMK-1 cell were incubated with different concentrations of TMAO (0, 1uM, 10uM, 100 uM, 1mM, 10mM, 100mM, 200, 500mM) for 24h, 48h and 72h to measure cell viability using a cell counting kit-8. Western blotting and qRT-PCR was used to detect the changes of related proteins and RNA after exposure to TMAO (100mM) for 48h and 72h.


In the present study, we found that circulating TMAO increased with age in mice. In vitro, we demonstrated that prolonged TMAO treatment induced senescence in HK-2 and TCMK-1 cell, characterized by reduced cell proliferation, increased expression of senescence-associated β-galactosidase (SA-β-gal). Meanwhile, TMAO increased the expression of p53, p21, p16 and decreased phosphorylation of Rb expression. Furthermore, TMAO changed the expression of circRNAs.


In summary, these data suggest that elevated circulating TMAO during the aging process may deteriorate HK-2, TCMK-1cell senescence and renal aging, which is probably associated with the activation of the p53/p21/Rb pathway and the change of circRNAs.


  • Government Support - Non-U.S.